Prothena Corp Public (PRTA) Net Income Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) Net Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Prothena Corp Public | 469.41 Mn | 139.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.64% |
| Dec 31, 2025 | 6.85% |
| Sep 30, 2025 | -3.61% |
| Jun 30, 2025 | -36.77% |
| Mar 31, 2025 | -20.63% |
| Dec 31, 2024 | -21.89% |
| Sep 30, 2024 | -24.87% |
| Jun 30, 2024 | 44.17% |
| Mar 31, 2024 | -28.19% |
| Dec 31, 2023 | -24.61% |
| Sep 30, 2023 | 23.67% |
| Jun 30, 2023 | 1.83% |
| Mar 31, 2023 | 0.78% |
| Dec 31, 2022 | 16.36% |
| Sep 30, 2022 | 2.69% |
| Jun 30, 2022 | -18.45% |
| Mar 31, 2022 | -0.51% |
| Dec 31, 2021 | 7.49% |
| Sep 30, 2021 | 35.26% |
| Jun 30, 2021 | 21.82% |